Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline

NCT04682977 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04682977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline
Lead sponsor
University of Illinois at Chicago
Phase
Not applicable
Overall status
Completed
Start date
August 11, 2021
Completion date
March 1, 2024
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart disease (coronary artery disease, ischemic heart disease, hypertensive heart disease), uncontrolled diabetes (hba1c ≥ 10)